Insta
Sanofi’s Dengue Vaccine Gets FDA Nod But Conditions Apply; Dengvaxia Is World’s First Vaccine Against Dengue
Swarajya Staff
May 02, 2019, 08:06 PM | Updated 08:06 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The Food and Drug Administration (FDA) has given its approval for the use of Sanofi Pasteur’s Dengvaxia, the first vaccine against dengue fever, The Wall Street Journal reported.
The FDA approved the vaccine, Dengvaxia, subject to the condition that it can be used to treat people aged 9 to 16 with a laboratory-confirmed prior infection and living in areas where the disease is endemic (occurs regularly through the year).
In the US, the disease is particularly prevalent in Puerto Rico and a few other offshore territories and protectorates.
Dengvaxia was first approved in Mexico in 2015 and remains the world’s only approved vaccine against dengue but was subject to massive controversy when researchers found that it could worsen dengue in some people.
The Philippines is the only country in the world that has broadly used Dengvaxia, however, it revoked Sanofi’s product license and suspended the use of the vaccine after the company announced the findings of its post-marketing research.
A probe in Philippines also found ‘Causal Association’ between deaths and Sanofi Dengue Vaccine. Sanofi had however denied that its vaccine, the world’s first against dengue, had caused any deaths.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.